Home › Crohn's Disease › Colorado › Aurora
Crohn's Disease clinical trials in Aurora, CO
4 studies for Crohn's Disease are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RecruitingPhase 3
- University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 5026), Aurora
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- UCHealth Digestive Health Center - Anschutz Medical Campus-Site Number: 8400085, Aurora
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Children's Hospital Colorado - Aurora /ID# 255764, Aurora
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Recruiting
- University of Colorado, Aurora
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY33 studies
- St. Louis, MO19 studies
- Miami, FL19 studies
- Orlando, FL19 studies
- Boston, MA18 studies
- Houston, TX17 studies
- Atlanta, GA16 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- Cleveland, OH15 studies
- Colorado Springs, CO14 studies
- San Antonio, TX14 studies
Other studies in Aurora
- Cancer (all types)34 studies
- Colorectal Cancer33 studies
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer30 studies
- Type 1 Diabetes26 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Obesity20 studies
- Lung Cancer19 studies
- Melanoma18 studies
- Heart Failure17 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.